Evidence map›Paper›PMID 31387612›Full record

ArticleGenome biology2019

BART-Seq: cost-effective massively parallelized targeted sequencing for genomics, transcriptomics, and single-cell analysis.

Fatma Uzbas, Florian Opperer, Can Sönmezer, Dmitry Shaposhnikov, Steffen Sass, Christian Krendl, Philipp Angerer, Fabian J Theis, Nikola S Mueller, Micha Drukker

Abstract read
In one paragraph

Article in Genome biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Sample-multiplexing approaches for single-cell sequencing.Cellular and molecular life sciences : CMLS · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. HyPR-seq: Single-cell quantification of chosen RNAs via hybridization and sequencing of DNA probes.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Oligonucleotide Probe for TranscriptomeACS chemical biology · 2020
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fatma UzbasInstitute of Stem Cell Research, Helmholtz Center Munich, 85764, Neuherberg, Germany.
Florian OppererInstitute of Stem Cell Research, Helmholtz Center Munich, 85764, Neuherberg, Germany.
Can SönmezerInstitute of Stem Cell Research, Helmholtz Center Munich, 85764, Neuherberg, Germany.
Dmitry ShaposhnikovInstitute of Stem Cell Research, Helmholtz Center Munich, 85764, Neuherberg, Germany.
Steffen SassInstitute of Computational Biology, Helmholtz Center Munich, 85764, Neuherberg, Germany.
Christian KrendlInstitute of Stem Cell Research, Helmholtz Center Munich, 85764, Neuherberg, Germany.
Philipp AngererInstitute of Computational Biology, Helmholtz Center Munich, 85764, Neuherberg, Germany.
Fabian J TheisInstitute of Computational Biology, Helmholtz Center Munich, 85764, Neuherberg, Germany.
Nikola S MuellerInstitute of Computational Biology, Helmholtz Center Munich, 85764, Neuherberg, Germany. nikola.mueller@helmholtz-muenchen.de.
Micha DrukkerInstitute of Stem Cell Research, Helmholtz Center Munich, 85764, Neuherberg, Germany. micha.drukker@helmholtz-muenchen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe a highly sensitive, quantitative, and inexpensive technique for targeted sequencing of transcript cohorts or genomic regions from thousands of bulk samples or single cells in parallel. Multiplexing is based on a simple method that produces extensive matrices of diverse DNA barcodes attached to invariant primer sets, which are all pre-selected and optimized in silico. By applying the matrices in a novel workflow named Barcode Assembly foR Targeted Sequencing (BART-Seq), we analyze developmental states of thousands of single human pluripotent stem cells, either in different maintenance media or upon Wnt/β-catenin pathway activation, which identifies the mechanisms of differentiation induction. Moreover, we apply BART-Seq to the genetic screening of breast cancer patients and identify BRCA mutations with very high precision. The processing of thousands of samples and dynamic range measurements that outperform global transcriptomics techniques makes BART-Seq first targeted sequencing technique suitable for numerous research applications.

Indexed as

Breast NeoplasmsCost-Benefit AnalysisEmbryonic Stem CellsFemaleGene Expression ProfilingGenomicsHigh-Throughput Nucleotide SequencingHumansPluripotent Stem CellsSequence Analysis, RNASingle-Cell AnalysisWnt Signaling PathwayWorkflowBarcodingHigh-throughput screeningHuman pluripotent stem cellsMultiplex PCRSingle-cell RNA sequencingTargeted transcriptomics

Identifiers

PMID31387612
PMCPMC6683345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.